Linus Pauling, the Nobel prize winner, was the first to promote the benefits of Vitamin C in the 1970’s. Since then intravenous (IV) Vitamin C has been extensively researched and is commonly used as an effective adjunctive cancer treatment. In the IV form, it has been used for decades in Europe, Canada, USA and Mexico.
Research has shown that infusion of high-dose IV vitamin C is preferentially toxic to cancerous cells (acting as a ‘pro-oxidant’) while being protective of non-cancerous cells. Laboratory and clinical studies indicate that in high enough doses, one can maintain blood plasma concentrations of ascorbate high enough to selectively kill tumor cells. IV Vitamin C can also be taken before and after standard chemotherapy, radiation, and surgery, which may improve overall results and may reduce the side effects of these therapies.
Additionally, intravenous vitamin C in combination with other vitamins, minerals, antioxidants, and amino acids can also be effective for a variety of health conditions.